LA LIBERATION DES SUBSTANCES MEDICAMENTEUSES A PARTIR DES COMPRIMES. II. LA LIBERATION DE LA MERCAPTO-PURINE A PARTIR DE DIFFERENTES MASSES POUR COMPRIMESNERLO H; CZARNECKI W.1975; ACTA POLON. PHARM.; POLOGNE; DA. 1975; VOL. 32; NO 3; PP. 365-370; ABS. RUSSE ANGL.; BIBL. 9 REF.Article

Syndrome mains-pieds secondaire à la prise de 6-mercaptopurine chez un enfant de quatre ans = 6-mercaptopurine-related hand-foot syndrome in a four-year-old childGIACCHERO, D; MONPOUX, F; CHIAVERINI, C et al.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 8-9, pp 580-583, issn 0151-9638, 4 p.Article

REDUCED FORMS OF AMINOPTERIN AND METHOTREXATE IN L1210 LYMPHOMA.MAKULU DR; FOLSCH E.1977; J. NATION. CANCER INST.; U.S.A.; DA. 1977; VOL. 59; NO 1; PP. 245-249; BIBL. 14 REF.Article

COMBINATION 6-MERCAPTOPURINE AND 6-METHYLMERCAPTOPURINE RIBOSIDE IN THE TREATMENT OF ADULT ACUTE LEUKEMIA: A SOUTHWEST ONCOLOGY GROUPHEWLETT JS; BODEY GP; WILSON HE et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 1; PP. 156-158; BIBL. 5 REF.Article

How low is too low? Use of cluster analysis to define low levels of mercaptopurine metabolitesTRAORE, Fatoumata; O'RIORDAN, Mary Ann; MYERS, Carolyn et al.Pediatric blood & cancer. 2006, Vol 46, Num 2, pp 187-192, issn 1545-5009, 6 p.Article

DEVELOPMENT OF RESISTANCE TO COMBINATIONS OF SIX ANTIMETABOLITES IN MICE WITH L1210 LEUKEMIASCHMID FA; HUTCHISON DJ; OTTER GM et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 1; PP. 23-27; BIBL. 21 REF.Article

INTERFERENCE OF 6-MERCAPTOPURINE RIBOSIDE, 6-METHYL-MERCAPTOPURINE RIBOSIDE AND AZATHIOPRINE WITH THE MORPHOGENETIC DIFFERENTIATION OF MOUSE EXTREMITIES IN VIVO AND IN ORGAN CULTURE.NEUBERT D; LESSMOLLMANN U; HINZ N et al.1977; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1977; VOL. 298; NO 2; PP. 93-105; BIBL. 29 REF.Article

Toxic ingestion of 6-mercaptopurine by young siblings of pediatric oncology patientsCHOW, Lionel M. L; CAPRA, Michael; LEVICHEK, Zina et al.The Journal of pediatrics. 2004, Vol 144, Num 5, pp 669-671, issn 0022-3476, 3 p.Article

Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicityNYGAARD, Ulrikka; TOFT, Nina; SCHMIEGELOW, Kjeld et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 4, pp 274-281, issn 0009-9236, 8 p.Article

In vitro metabolism of 6-mercaptopurine by human liver cytosolROWLAND, K; LENNARD, L; LILLEYMAN, J. S et al.Xenobiotica (London. Print). 1999, Vol 29, Num 6, pp 615-628, issn 0049-8254Article

SPECTRAL CHARACTERISTICS OF SOME METALLO COMPLEXES OF SIX-MERCAPTOPURINELEWIS RW; OLIVIER G.1976; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 13; NO 1; PP. 137-140; BIBL. 14 REF.Article

DOMINANT LETHAL TEST IN MICE WITH 6-MERCAPTOPURINE.SCHENCKING MS; FROHBERG H.1975; ARCH. TOXICOL.; GERM.; DA. 1975; VOL. 34; NO 1; PP. 71-75; ABS. ALLEM.; BIBL. 13 REF.Article

A GAS CHROMATOGRAPHIC METHOD FOR MEASURING 6-MERCAPTOPURINE IN SERUM.BAILEY DG; WILSON TW; JOHNSON GE et al.1975; J. CHROMATOGR.; NETHERL.; DA. 1975; VOL. 111; NO 2; PP. 305-311; BIBL. 7 REF.Article

IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY PROPERTIES OF CYCLOPHOSPHAMIDE, AZATHIOPRINE AND METHOTREXATEHURD ER.1973; ARTHRIT. AND RHEUMATISM; U.S.A.; DA. 1973; VOL. 16; NO 1; PP. 84-88; BIBL. 22REF.Serial Issue

EXPERIENCE DE L'UTILISATION DE PRODUITS CYTOSTATIQUES DANS LE TRAITEMENT D'ASSOCIATION DE L'ARTHRITE RHUMATOIDE CHEZ L'ENFANT1972; VEST. AKAD. MED. NAUK; S.S.S.R.; DA. 1972; NO 12; PP. 67-70; ABS. ANGL.; BIBL. 1/2P.Serial Issue

THE INITIAL STUDY OF THE IMMUNOSUPPRESSIVE EFFECTS OF 6-MERCAPTOPURINE AND AZATHIOPRINE IN ORGAN TRANSPLANTATION AND A FEW WORDS ON CYCLOSPORIN ACALNE RY.1982; WORLD J. SURG.; ISSN 0364-2313; DEU; DA. 1982; VOL. 6; NO 5; PP. 637-640; BIBL. 20 REF.Article

THE INFLUENCE OF 6-MERCAPTOPURINE AND SOME OF ITS DERIVATIVES ON HUMAN ERYTHROCYTE PHOSPHOFRUCTOKINASELINDEMANS BANZIGER CIM; VAN DER STEEN ATM; STAAL GEJ et al.1976; J. MOLEC. MED.; NETHERL.; DA. 1976; VOL. 1; NO 2; PP. 117-125; BIBL. 27 REF.Article

INFLUENCE DE LA MERCAPTO-6 PURINE SUR L'INCORPORATION DU ³²P-ORTHOPHOSPHATE DANS LES NUCLEOTIDES PURINIQUES ACIDO-SOLUBLES DANS LA TUMEUR MYELOIDE MURINE, YCL/T20 (GRAFI)CHELIBONOVA LORER KH; YAKIMOV M; GOLOVINSKIJ E et al.1973; VOPR. MED. KHIM.; S.S.S.R.; DA. 1973; VOL. 19; NO 2; PP. 191-193; ABS. ANGL.; BIBL. 7REF.Serial Issue

EFFECT OF ALLOPURINOL ON THE PHARMACOKINETICS OF 6-MERCAPTOPURINE (NSC755) IN CANCER PATIENTSCOFFEY JJ; WHITE CA; LESK AB et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 6; PP. 1283-1289; BIBL. 14REF.Serial Issue

THERAPEUTIC TRIAL OF IMMUNOSUPPRESSIVE AGENTS IN MULTIPLE SCLEROSISNEUMANN JW; ZIEGLER DK.1972; NEUROLOGY; U.S.A.; DA. 1972; VOL. 22; NO 12; PP. 1268-1271; BIBL. 24REF.Serial Issue

Dose-response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in micePLATZEK, T; BOCHERT, G.Teratogenesis, carcinogenesis, and mutagenesis. 1996, Vol 16, Num 3, pp 169-181, issn 0270-3211Article

6-MERCAPTOPURIN-PROTEIN-KONJUGATE MIT FLEXIBLER KETTE. XVIII. IMMUNSUPPRESSIVA-ANTIGEN-KONJUGATE. = CONJUGUES MERCAPTO-6 PURINE-PROTEINE AVEC UNE CHAINE FLEXIBLE. XVIII. CONJUGUES IMMUNOSUPPRESSEURS-ANTIGENENUHN P; MATTHES K; WAGNER G et al.1977; PHARMAZIE; DTSCH.; DA. 1977; VOL. 32; NO 11; PP. 684-687; BIBL. 17 REF.Article

DOSAGE POTENTIOMETRIQUE DE LA MERCAPTOPURINE ET DE LA MERCAZOLINE DANS LES COMPRIMESGEJN LG; RUBTSOV VK; SUMBAJKINA ZA et al.1975; FARMACIJA; S.S.S.R.; DA. 1975; VOL. 24; NO 3; PP. 70-72; BIBL. 10REF.Article

PROPRIETES ANTIINFLAMMATOIRES DE QUELQUES IMMUNODEPRESSEURSZAKS AS; RABOTNIKOV YU M; OVODENKO LA et al.1975; FARMAKOL. I TOKSIKOL.; S.S.S.R.; DA. 1975; VOL. 38; NO 5; PP. 587-589; ABS. ANGL.; BIBL. 1/2 P.Article

INDIKATIONEN ZUR ZYTOSTATISCHEN BEHANDLUNG VON PATIENTEN MIT OSTEOMYELOSKLEROSE BZW.-FIBROSE = INDICATIONS AU TRAITEMENT CYTOSTATIQUE DES OSTEO-MYELOSCLEROSES OU OSTEO-MYELOFIBROSESENGELMANN C; SCHULZ K; NOWOTNY P et al.1972; DTSCHE GESUNDH.-WES.; DTSCH.; DA. 1972; VOL. 27; NO 50; PP. 2375-2380; ABS. RUSSE ANGL.; BIBL. 45REF.Serial Issue